Our Business Development team invites you to contact them to explore your potential development and commercialization applications using our xMAP® technology. Click here to start the conversation now.
了解更多
The Faces of Luminex: Stephen Angeloni, Field Applications
Maybe you’ve come up with a great new idea for a multiplex assay, but you need some assistance optimizing the reagents. Or perhaps you just want some training in assay design to streamline internal development. When it comes to helping customers make the most of their xMAP® Technology, Stephen Angeloni is there. As a Maryland-based Senior Field Application Scientist, he works closely with customers to make sure their assays run as smoothly as possible. He earned his PhD in biochemistry from Virginia Tech and has been with Luminex since 2011.
Continue Reading >
xMAP Technology makes up the basis of Luminex’s core business. This flexible technology is centered on the use of Luminex xMAP Microspheres.
Watch more videos >
October 18
Luminex Corporation to Acquire MilliporeSigma’s Flow Cytometry Portfolio
October 15
Luminex Corporation Third Quarter Earnings Release Scheduled for November 5, 2018
September 11
Luminex Corporation Declares Third Quarter Cash Dividend
September 6
Luminex Corporation to Present at the Morgan Stanley 16th Annual Global Healthcare Conference
August 6
Luminex Corporation Reports Second Quarter 2018 Financial Results
AMP Annual Meeting
November 1-3
San Antonio, TX
xMAP® Connect Amsterdam
November 6-7
Amsterdam, Netherlands
